Shortages of antibiotics, IV fluids and sterile injectables are hardening as new EU and US rules push pharma to fix the incentives behind them.
Manish Garg, PMP, PSM
Advertisement
Manish Kumar Garg is the associate director of IT, Applications, Serialization, and Track & Trace at Hikma.
Articles by Manish Garg, PMP, PSM
How the zero-prefix collision will disrupt reimbursement, patient access, brand protection and market intelligence — and what commercial leaders must do before 2033.
Advertisement
Latest Updated Articles
White Paper: The NDC-12 Revenue RiskMarch 26th 2026
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Will PBMs' TrumpRx Price Pledge Reach Prescribers?
2
Report: Mail-Order Pharmacy Satisfaction Climbs as Retail Trust Slips
3
Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine
4
AI In Pharmacovigilance: The Commercial and Market-Access Imperative
5